Shea butter and niacinamide cream may ease itching for immunotherapy patients
NCT ID NCT07337486
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether using creams with niacinamide and shea butter can prevent or reduce skin itching in cancer patients receiving immunotherapy. 130 adults with solid tumors starting checkpoint inhibitor treatment were randomly assigned to use either the test cream or a control cream for 6 months. The goal was to see if the special cream could improve skin comfort and quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN TOXICITY IN PATIENTS ON CHECKPOINT INHIBITORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital de la Santa Creu i Sant Pau
Barcelona, 08025, Spain